Remove Doctor Remove Doctors Remove Insulin
article thumbnail

Running Through Life with Type 1 Diabetes

Worldwide Clinical Trials

I was diagnosed with Type 1 diabetes, an autoimmune disease where the pancreas stops producing insulin, unlike Type 2 diabetes, where the body doesn’t produce enough or use it properly. There’s no cure and managing Type 1 requires multiple daily insulin injections (MDI) or an insulin pump.

Insulin 162
article thumbnail

Drug Channels News Roundup, April 2022: 340Boom, 340B Profits for Pharmacies & PBMs, Fixing Insulin, Walgreens’ Robots, and Doctors’ Day

Drug Channels

In this issue: Green Monster : The 340B market hits new highs in 2021 Not-Free Agents : Big 340B profits for CVS, Walgreens, Express Scripts, et al Batter Up : Fixing the insulin market Pinch Hitters : Walgreens bets on robots Plus, Dr. Glaucomflecken helps UnitedHealthcare celebrate Doctors’ Day!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

World Diabetes Day 2024: Advanced Care for Diabetes Management

XTalks

Cure Research: Moving Toward an Insulin-Free Future JDRF is focused on funding research that is accelerating the development of new treatments for people with T1D — for all ages and stages. “Our before people need insulin therapy), so that it’s possible to intervene with therapies that can stop clinical disease before it starts.”

Insulin 108
article thumbnail

National Diabetes Month 2024: Take Charge of Tomorrow — Preventing Diabetes Health Problems

XTalks

Diabetes, a chronic condition marked by high blood glucose levels due to insulin issues, brings complications like heart disease, stroke, neuropathy and diabetic foot ulcers. Abbot also joined Medtronic to pair its sensors with the latter’s automated insulin delivery (AID) systems. million undiagnosed and 115.9

Insulin 105
article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

Continuing advancements within this field deliver new hope to doctors and patients, transforming disease outcomes for previously incurable indications. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market.

Drugs 295
article thumbnail

Novo Nordisk launches first smart insulin pens for NHS patients

pharmaphorum

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time. Smart insulin pens are expected to drive the insulin pen market from $13.8

Insulin 52
article thumbnail

Roche debuts smart glucose monitor for hospital use

pharmaphorum

Roche has launched what it says is a first-of-its kind handheld glucose management device, backed up by a digital platform that aims to simplify the work of doctors and nurses as they deliver care to patients. The post Roche debuts smart glucose monitor for hospital use appeared first on.

Insulin 128